BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs

Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public by merging with a Cormorant-sponsored SPAC. The combined company will continue developing drugs targeting various forms of mutated KRAS proteins that drive cancers. The post BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs appeared…

Read More

Fires Undercut L.A.’s Headway on Homelessness

Los Angeles County homelessness leaders last year reported nearly 30,000 permanent housing placements — an annual high for the sprawling region of 10 million residents. Thousands more got into shelter and short-term housing. Gov. Gavin Newsom and local leaders celebrated the progress as evidence that an unprecedented multibillion-dollar public investment to move people off the…

Read More

Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces

To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures. The post Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces appeared first on MedCity News.

Read More